FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
WHO prequalifies Roche's tocilizumab as its first monoclonal antibody treatment for COVID-19 - Homeland Preparedness News
:quality(90)/ "Roche | Actemra")
Roche | Actemra
Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential - Ghasemi - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates - ABC News
Roche's arthritis drug lowers deaths in hospitalised Covid-19 patients
Approval lapsed) RoActemra tocilizumab 400 mg/ 20mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Approval lapsed) RoActemra tocilizumab 80mg/4mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Roche's Actemra fails to meet Phase III goals in Covid-19 patients
Is PMR the Next Indication for Tocilizumab? | MedPage Today
Roche Suspends Patents On Tocilizumab In LMICs After WHO Recommends It As Treatment For Severe COVID-19 - Health Policy Watch
Roche (Genentech) - Actemra®(tocilizumab)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QFWUTH5BLZN5LGWVT27LGWPZBE.jpg "Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters")
Roche arthritis drug reduces COVID-19 deaths in trial in hospitalised patients | Reuters
USTC Global on X: "The mechanism of using Tocilizumab to cure severe patients of COVID-19. @NIH @CDC @DrAiLynTan #coronavirus #COVID19 #CoronavirusOutbreak #coronaviruskorea #ItalyCoronavirus #italylockdown #IranCoVidTruth #Tocilizumab https://t.co ...
WHO adds Roche's arthritis drug tocilizumab to COVID-19 medicines list | Reuters
FDA approves Roche's Actemra for COVID-19
Delhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working Information from Roche – Spicyip
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
WHO Urges Covid-19 Treatment With Roche and Sanofi Anti-Inflammatory Drugs - WSJ
Tocilizumab May Benefit Certain Severe COVID-19 Patients | MedPage Today
Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
Roche won't contest Hetero Drug's tocilizumab copy | Mint
Actemra; coronavirus complications to be treated under Chinese approval
